Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies

Janie Parrino, Shelly A. McNeil, Steven J. Lawrence, Eva Kimby, Marco F. Pagnoni, Jon E. Stek, Yanli Zhao, Ivan S.F. Chan, Susan S. Kaplan

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)
Original languageEnglish
Pages (from-to)1764-1769
Number of pages6
JournalVaccine
Volume35
Issue number14
DOIs
Publication statusPublished - Mar 27 2017

ASJC Scopus Subject Areas

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies'. Together they form a unique fingerprint.

Cite this